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Background:Obesity has been associatedwith subclinical diastolic dysfunction and increased risk of heart failure.
Our aims were to evaluate the age- and sex-speciﬁc role of total and abdominal adiposity on diastolic function
and to assess the direct and indirect pathophysiological mechanisms involved in this association.
Methods and results:Within a population-based study (EPIPorto), a total of 1063 individuals aged≥ 45 years (62%
female; 62.4 ± 10.6 years) were evaluated using echocardiography, anthropometrics, electrical bioimpedance
and blood tests. Diastolic function was assessed with using EAE/ASE consensus criteria.
Worse diastolic function grades were associated with increased BMI, fat mass % and waist-to-height ratio (p for
trend b 0.001). The inverse association between adiposity and diastolic function was stronger in men and in the
younger population. In multivariate analysis, waist-to-height ratio (per cm/cm) was associated with reduced E′
velocity (adjusted β:−14.4; 95% CI:−21.1 to−7.6; p b 0.001) and increased E/E′ ratio (adjusted β: 9.7, 95% CI:
5.4–10.0; p b 0.001), among men b 65 years.
Both direct and indirect mechanisms were involved in the E′ velocity decrease by waist-to-height ratio in
participants b 65 years. The effect was mainly direct in men (81.3%), while it was mostly indirect in women,
through systolic blood pressure (50.8%) and inﬂammation (15.1%).
Conclusions: Adiposity, especially abdominal, was associated with worse diastolic function. This association was
more important inmen and in the younger population. The causal mechanisms involvedwere sex-speciﬁc, with
mostly direct effects among men and blood-pressure-mediated among women.© 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
In heart failure progression, alterations in myocardial structure and
function appear before the onset of symptoms, a process knownasmyo-
cardial remodeling [1]. Recent heart failure guidelines give special em-
phasis to the early detection of these asymptomatic changes on left
ventricle (LV) systolic and diastolic functions and the identiﬁcation of
its main risk factors [2,3].
Heart failure with preserved ejection fraction (HFpEF), accounts for
approximately 50% of heart failure patients [4,5] and its prevalence is
increasing [4]. Several pathophysiological mechanisms are involved int, Gaia Hospital Center, Rua
-Carvalho).
.HFpEF [6], but it is clear that diastolic dysfunction (caused by alterations
in myocardial relaxation and/or increased left ventricle stiffness) is
present in nearly all of these patients [7]. Therefore, current consensus
guidelines recommend that evidence of abnormal LV diastolic function
should be required for the diagnosis of HFpEF [3,8]. Population-based
studies and registries have shown that patients with HFpEF are older,
more frequentlywomen,with a higher prevalence of hypertension, atri-
al ﬁbrillation, diabetes and obesity [4].
Obesity has reached epidemic proportions worldwide and is now
recognized as an independent risk factor for heart failure [9–11] and
other cardiovascular diseases [10,12]. Recent studies have shown that
increased body mass index can induce subclinical LV diastolic dysfunc-
tion (DD) [13], suggesting that DD can be one of the pathophysiological
links between obesity and heart failure [11,12]. Obesity can induce DD
by several potential mechanisms [14,12]. The effect can be direct by
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state [17,18] and changes in LV hemodynamics [19,20], or indirect
through its association with other cardiovascular risk factors, such as
hypertension, insulin resistance and diabetes [10]. The role of central
versus total adiposity on diastolic function is lesswell characterized. Ab-
dominal obesity is associated with excess visceral fat, which is a meta-
bolically more active fat, and probably a more important determinant
of cardiac function and cardiovascular disease than total adiposity
[21]. In addition, it is known that the distribution of fat is different be-
tween men and women and that age also induces important changes
in the quantity of fat and its anatomic distribution.
In this studywe aimed to evaluate: 1) the role of abdominal and total
adiposity parameters in diastolic dysfunction; 2) the inﬂuence of sex
and age on this association; and 3) the direct (adiposity mediated)
and indirect (blood-pressure- and inﬂammation-mediated) mecha-




Participants were selectedwithin the ﬁrst follow-up of a cohort, rep-
resentative at baseline of the adult population of Porto, Portugal — the
EPIPorto cohort study. In 1999–2003, the cohort assembly was made
by random-digit dialing, using households as the sampling frame,
followed by random selection of one person aged 18 years or older in
each household. Refusals were not substituted within the same house-
hold. The proportion of participation was 70% [22]. At baseline, 2485
participants were recruited. Between October 2006 and July 2008, par-
ticipants aged 45 years or over were eligible to a systematic evaluation
of parameters of cardiac structure and function, which included a cardio-
vascular clinical history, physical examination, detailed anthropometric
evaluation, collection of fasting blood sample and a transthoracic echocar-
diogram. Among 2048 cohort members in the eligible age range at this
time, 134 (6.5%) had died, 198 (9.7%) refused to be re-evaluated and
580 (28.3%) were lost to follow-up (unreachable by telephone or post).
For the present analysiswe excluded73 patientswith previousmyocardi-
al infarction, percutaneous or surgical revascularization, prior cardiac sur-
gery or signiﬁcant (moderate to severe) valvular heart disease. Written
informed consent was obtained from all the individuals and the local
ethics committee approved the study.
2.2. Clinical variable deﬁnitions
Hypertension was deﬁned as systolic blood pressure ≥ 140 mm Hg
or diastolic blood pressure ≥ 90 mm Hg at the time of the visit (mean
of 2 readings) or use of antihypertensive medication. Diabetes was de-
ﬁned as fasting blood glucose ≥ 126 mg/dL or the patient's self-reported
history of diabetes or use of diabetes medications. Hypercholesterolemia
was deﬁned as total serum cholesterol ≥ 220 mg/dL or the use of lipid-
lowering drug treatment.
2.3. Anthropometric evaluation
Measurements included height, weight, waist circumference, and
hip circumference. Body mass index (BMI) (weight/height2 in kg/m2)
was calculated for each subject. Waist circumference was measured at
the midpoint between the iliac crest and the lower rib margins mea-
sured in the midaxillary line. Overweight was deﬁned as BMI ≥ 25
and below 30 kg/m2, and obesity as BMI ≥ 30 kg/m2. Hip-to-height
and waist-to-height ratios were calculated as the ratio between hip cir-
cumference (cm) or waist circumference (cm), respectively, and height
(cm). Body composition was assessed by bioelectrical impedance anal-
ysis (Tanita Corp, Arlington Heights, IL) to determine body fat percent-
age (%).2.4. Analytical data
A fasting venous blood samplewas obtained in themorning formea-
surement of glucose, total cholesterol, LDL, HDL, triglycerides and high-
sensitivity C-reactive protein (by immunonephelometry).
2.5. Echocardiography data
All echocardiography studies were acquired by one of four cardiolo-
gists, using the same equipment (Hewlett-Packard Sonos 5500). Images
were stored on videotape for posterior ofﬂine analysis by two experi-
enced cardiologists, blinded to clinical data.
Cardiac chamber dimensions, volumes and left ventricular mass were
measured according to current recommendations [23], and indexed to
body surface area. Diastolic functionwas assessed according to the recent
consensus guidelines on diastolic function evaluation [24] measuring mi-
tral inﬂowvelocities (E-wave, Awave, E/A ratio) and E-wave deceleration
time (DT) and isovolumetric relaxation time (IVRT) using pulsed-wave
(PW) Doppler in the apical four-chamber view. Velocities were recorded
at end-expiration and averaged over three consecutive cardiac cycles. PW
tissue-Doppler velocities were acquired at end expiration, in the apical
four-chamber view, at the lateral side of the mitral annulus, measuring
early diastolic (E′) and late diastolic (A′) velocities and estimating the
E/E′ ratio accordingly. Following the recommendations in the consensus
document, patients were categorized by two independent cardiologists
in DD grades: grade I (mild DD) if E′ lateral b 10 cm/s and E/A b 0.8,
DT N 200 ms, E/E ≤ 8; grade II (moderate DD) if E′ lateral b 10 cm/s and
E/A between 0.8 and 1.5, DT 160–200ms, E/E′ 9–12; and grade III (severe
DD), if E′ lateral b 10 cm/s and E/A≥ 2, DT b 160, E/E′≥ 13. In case of dis-
cordance, each case was discussed individually. Systolic function was
evaluated by ejection fraction calculation using the modiﬁed biplane
Simpson's rule.
2.6. Statistical analysis
Statistical analyses were performed using SPSS statistics 20 (IBM
Corp, Armonk, NY). All p values are 2-tailed and a signiﬁcance level of
5% was used. Data are expressed as mean and standard deviation for
quantitative variables or number (n) and percentage (%) for categorical
variables. Because C-reactive protein was not normally distributed, a
logarithmic transformation was performed, achieving a normal distri-
bution of this variable.
The determinants of E′ velocity and E/E′ ratio were explored
using linear regression analysis. To analyze the determinants of dia-
stolic dysfunction, logistic regression analysis was performed. The
association between adiposity and all diastolic function parameters
was analyzed stratifying by sex and age (cut-off: 65 years) and ad-
justing for age and systolic blood pressure (continuous variables).
Adjustment for age (continuous) within age strata intended to con-
trol for residual confounding.
Path analysis is an extension of regression analysis which allows
for the simultaneous estimation of the interrelations between vari-
ables in a set [25]. This technique is being increasingly used to de-
compose and compare the magnitudes of effects between variables
with complex interrelations or to test the plausibility of mediation
effects. We conducted path analysis assuming the possible causal
model depicted in Fig. 1. Models were ﬁtted with Mplus software
(Muthén and Muthén, Los Angeles, CA); 95% conﬁdence intervals
were calculated by bootstrapping; and goodness of ﬁt was evaluated
using the comparative ﬁt index (CFI). Models were considered to
have good ﬁt if CFI was higher than 0.90.
3. Results
The ﬁnal analysis included 1063 participants with a mean age of
62.4 ± 10.6 years and 62.0% were women. Table 1 shows the clinical,
Fig. 1. Hypothesized causal mechanisms linking abdominal adiposity and diastolic
dysfunction.
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study sample, by sex. Therewas a high prevalence of cardiovascular risk
factors, especially hypertension and dyslipidemia.
The total prevalence of diastolic dysfunction was 23.1%: 14.2% had
mild diastolic dysfunction and 8.9% had moderate or severe diastolic
dysfunction, as shown in Table 2. No signiﬁcant differences wereTable 1
Characteristics of the study sample, by sex.
Women (n = 659) Men (n = 404)
Clinical data
Age, years 62.0 ± 10.3 63.1 ± 11.1
Cardiovascular risk factors
Hypertension (%) 465 (70.6%) 293 (72.5%)
Diabetes (%) 75 (11.4%) 51 (12.6%)
Dyslipidemia (%) 379 (57.5%) 204 (50.5%)
Obesity (%) 207 (31.4%) 55 (13.6%)
Systolic blood pressure, mm Hg 134.9 ± 22.0 134.9 ± 18.0
Diastolic blood pressure, mm Hg 81.4 ± 11.0 82.0 ± 10.3
Adiposity parameters
BMI, kg/m2 28.2 ± 5.1 26.5 ± 3.7
Waist circumference/height, cm/m 0.89 ± 0.08 0.57 ± 0.06
Hip circumference/height, cm/m 0.67 ± 0.07 0.59 ± 0.04
Waist-to-hip ratio 0.89 ± 0.07 0.97 ± 0.06
Fat mass, % 35.5 ± 6.9 24.3 ± 5.5
Analytical data
Total cholesterol, mg/dL 220.1 ± 51.7 214.1 ± 56.7
HDL, mg/dL 61.5 ± 43.1 56.8 ± 48.6
LDL, mg/dL 134.0 ± 51.1 131.0 ± 57.1
Triglycerides, mg/dL 151.1 ± 43.8 167.9 ± 50.3
Glucose, mg/dL 102.0 ± 43.1 108.6 ± 53.0
Log hs-CRP, mg/dL −0.68 ± 0.46 −0.77 ± 0.50
Echocardiography
Septum, mm 8.4 ± 1.4 9.1 ± 1.4
Posterior wall, mm 7.7 ± 1.2 8.4 ± 1.3
LV mass index, g/m2 86.7 ± 18.1 86.8 ± 24.2
Left atrium volume index, mL/m2 29.7 ± 10.9 29.7 ± 12.4
LV end-diastolic volume, mL/m2 63.6 ± 15.8 71.6 ± 18.7
LV end-systolic volume, mL/m2 25.6 ± 9.1 25.6 ± 9.1
Ejection fraction, % 61.1 ± 6.3 58.5 ± 7.7
E wave, cm/s 73.7 ± 15.8 67.9 ± 15.2
A wave, cm/s 81.2 ± 20.2 74.2 ± 18.6
E/A ratio 0.96 ± 0.32 0.96 ± 0.33
Deceleration time, ms 234.8 ± 52.7 242.9 ± 63.3
IVRT, ms 91.5 ± 16.1 92.6 ± 16.1
E′ velocity, cm/s 10.4 ± 3.2 10.5 ± 3.3
E/E′ ratio 7.7 ± 2.8 7.0 ± 2.6
Diastolic dysfunction (DD) grade
Normal diastolic function, n (%) 482 (73.1%) 310 (76.7%)
Mild DD, n (%) 99 (15.0%) 52 (12.9%)
Moderate/severe DD, n (%) 63 (9.6%) 32 (7.9%)
Data are presented as mean and standard deviation for continuous variables and count
and percentage for categorical variables.
BMI, body mass index; hs-CRP, high sensitivity C reactive protein; DD, diastolic dysfunction;
IVRT, isovolumetric relaxation time; LV, left ventricle.found in DD grades according to sex (p = 0.20). In 25 patients (2.4%)
it was not possible to determine DD grade due to atrial ﬁbrillation or fu-
sion of the E/A mitral ﬂow pattern. Patients with diastolic dysfunction
were older, had increased systolic and diastolic blood pressure and
higher levels of C-reactive protein. Left ventricle mass was higher in pa-
tientswith diastolic dysfunction,which also showed decreased E′ veloc-
ities and increased E/E′ ratio.
3.1. Adiposity parameters and diastolic dysfunction grades
Overall, overweight and obese participants had higher prevalence of
diastolic dysfunction: 27.0% in the overweight, 26.3% in the obese and
14.7% in individuals with BMI b 25 kg/m2. In addition, as shown in
Table 2, participants with diastolic dysfunction had a signiﬁcant in-
crease in BMI, fat mass percentage, waist circumference/height, hip-
circumference/height andwaist-to-hip ratio (p b 0.001). The association
between diastolic function and adiposity parameters was different ac-
cording to sex and age.
3.2. Adiposity and diastolic dysfunction in women
Overall, in women there was no signiﬁcant relation between BMI and
E′ velocity or E/E′ ratio, after adjustment for age and systolic blood pres-
sure, either below or above 65 years of age. However, in women younger
than65yearsweobserved a signiﬁcant associationbetween total fatmass
percentage and E′ velocity, even after adjustment for age and systolic
blood pressure (Table 3).
In women the association between abdominal adiposity, assessed
by waist-to-height ratio, and E′ velocity was different according to age
(p for interaction = 0.01). In women b 65 years, waist-to-height ratio
was associated with decreased E′ velocity (r =−0.21; crude β:−8.0,
95% CI:−11.8 to−4.3; p b 0.01) but, after adjustment for SBP, we ob-
served an attenuation of this association (adjusted β: −2.3; 95% CI:
−6.1 to 1.6; p = 0.25). In this subgroup, a similar association was ob-
served between waist-to-height ratio and E/E′ ratio (crude β: 4.3, 95%
CI: 1.7 to 6.8; p = 0.001), which was no longer signiﬁcant after adjust-
ment for SBP.
3.3. Adiposity and diastolic dysfunction parameters in men
In men, BMI was associated with decreased E′ velocity (p b 0.001),
increased E/E′ ratio (p b 0.001) and a higher likelihood of diastolic dys-
function (adjusted OR: 1.17; 95% CI: 1.09–1.27; p b 0.001), even after ad-
justment for age and SBP.We also found an association between fat mass
percentage with E′ velocity (p b 0.001) and E/E′ ratio (p b 0.001). The as-
sociation between DD and BMI or fat mass % was signiﬁcant in both age
groups, but stronger in younger men (p for interaction of 0.03 and 0.04,
respectively), as shown in Table 3.
In men younger than 65 years, E′ velocity was more strongly corre-
lated with abdominal obesity, namely with waist-to-height ratio, than
with BMI. After adjustment for age and SBP, waist-to-height ratio was
associated with decreased E′ velocity and increased E/E′ ratio (adjusted
β: 9.7, 95% CI: 5.4–10.0; p b 0.001). In men older than 65 years, we also
observed an association between waist-to-height ratio and E′ velocity,
but of lesser magnitude compared to younger patients (Table 3).
3.4. Pathophysiological path analysis for the association between
waist-to-height ratio and diastolic function
Fig. 1 shows schematically the testedmodel for the path analysis be-
tween waist-to-height ratio and E′ velocity. Table 4 presents the esti-
mated total, direct and indirect effects of abdominal adiposity (waist-
to-height ratio) on E′ velocity.
Inmen, the association betweenwaist-to-height ratio and E′ velocity
was signiﬁcant in both age groups andmainly determined by a direct ef-
fect. As shown in Table 4, in men younger than 65 years, 81.3% of the
Table 2
Clinical characteristics according to diastolic dysfunction grades.
Normal diastolic function
n = 792 (74.5%)
Mild diastolic dysfunction
n = 151 (14.2%)
Moderate or severe diastolic dysfunction
n = 95 (8.9%)
p value for trend
Age, years 59.9 ± 10.0 70.3 ± 8.7 68.0 ± 8.7 b0.001
Female, n (%) 482 (60.8%) 99 (65.5%) 63 (66.3%) 0.58
Hypertension, n (%) 380 (60.6%) 265 (85.2%) 69 (95.7%) b0.001
Systolic blood pressure, mm Hg 131.6 ± 19.4 147.0 ± 23.1 141.7 ± 18.3 b0.001
Diastolic blood pressure, mm Hg 81.1 ± 10.5 83.3 ± 11.4 63.3 ± 11.1 0.02
Log hsCRP, mg/dL 0.18 0.21 0.24 b0.001
Adiposity parameters
BMI, kg/m2 27.1 ± 4.6 28.1 ± 4.2 28.3 ± 4.3 b0.001
Fat mass, % 30.6 ± 8.6 33.4 ± 7.3 33.9 ± 7.3 b0.001
Waist-to-height ratio, cm/cm 0.58 ± 0.07 0.61 ± 0.07 0.60 ± 0.06 b0.001
Hip-to-height ratio, cm/cm 0.63 ± 0.07 0.65 ± 0.06 0.64 ± 0.06 b0.001
Waist-to-hip ratio 0.91 ± 0.08 0.94 ± 0.07 0.94 ± 0.08 b0.001
Echocardiography
LA volume index, mL/m2 28.7 ± 9.5 30.0 ± 11.7 30.4 ± 12.3 0.35
LV mass index, g/m2 76.7 ± 17.0 91.6 ± 21.8 91.7 ± 29.9 b0.001
E′ velocity, cm/s 11.7 ± 2.7 6.4 ± 1.0 6.6 ± 1.1 b0.001
E/E′ ratio 6.4 ± 1.7 9.6 ± 2.5 11.9 ± 3.4 b0.001
E/A ratio 1.0 ± 0.3 0.6 ± 0.1 1.0 ± 0.4 b0.001
Deceleration time, ms 230.0 ± 48.9 286.9 ± 75.6 234.0 ± 50.2 b0.001
IVRT, ms 90.8 ± 14.8 101.2 ± 15.9 90.9 ± 18.8 b0.001
Data are presented as mean and standard deviation for continuous variables and count and percentage for categorical variables.
BMI, body mass index; BP, blood pressure; hsCRP, high sensitivity C-reactive protein; IVRT, isovolumetric relaxation time; LA, left atrium; LV, left ventricle.
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mediated by inﬂammation (−1.954;−3.902 to−0.005) and 6.3% via
SBP (−0.982; 95% CI: −3.301 to 1.336). In men older than 65 years,
most of the effect was also direct (92.0%).
In women, we found an association between abdominal adiposity
and E′ velocity only in the younger group. Contrary to men, most of
the effect of waist-to-height ratio on E′ velocity was indirect, mainly
through SBP (50.8%), with non-signiﬁcant proportions of 15.1% via in-
ﬂammation and 34.2% by direct effect (Table 4).4. Discussion
In this population-based studywe found that diastolic function is in-
dependently associated with several adiposity parameters, especially
abdominal adiposity. This association is more important in men and in
the younger population.Moreover, inmen, abdominal adipositywas re-
lated with worse diastolic function mainly by direct (adiposity mediat-
ed) mechanisms, while in women the predominant effect was indirect,
mainly through hypertension.Table 3
Univariate and multivariate linear regression analyses for the association between E′ velocity a
b65 years
Crude Adjusteda
β (95% CI) r β (95% CI) p
value
Women
BMI, kg/m2 −0.10 (−0.15 to−0.04) −0.17 −0.03 (−0.08 to 0.03) 0.30
Fat mass, % −0.11 (−0.15 to−0.07) −0.24 −0.04 (−0.09 to−0.01) 0.04
Waist/height,
cm/m
−8.0 (−11.8 to−4.3) −0.21 −2.7 (−6.4 to 1.0) 0.15
Men
BMI, kg/m2 −0.30 (−0.41 to−0.18) −0.33 −0.23 (−0.34 to−0.11) b0.001
Fat mass, % −0.19 (−0.26 to−0.11) −0.32 −0.14 (−0.21 to−0.06) b0.001
Waist/height,
cm/m
−19.6 (−13.3 to−25.8) −0.38 −14.4 (−21.1 to−7.6) b0.001
β, regression coefﬁcient; 95% CI, 95% conﬁdence interval; BMI, body mass index; r, correlation
a Adjusted for age (continuous) and systolic blood pressure (continuous).4.1. The association between diastolic dysfunction and adiposity
distribution parameters
In this study we have shown that increased BMI is independently
associated with worse diastolic function, which is in accordance with
previous studies showing the same independent association [13,26].
We observed that this association is more important in men and in
younger people. Considering that subclinical diastolic dysfunction is a
predictor of future heart failure risk [27], and BMI is known as an inde-
pendent risk factor for incident heart failure [9,28], it has been proposed
that diastolic dysfunction can be one of the important pathophysiologi-
cal links between obesity, heart failure andmortality [29]. Besides, some
studies have shown that long-term weight loss, for example after bar-
iatric surgery, can improve diastolic function [30,31], an observation
that supports this relation. However, it is known that BMI is an imper-
fect measure of fat mass, as it can be inﬂuenced by several other factors
[21]. In this study, we have shown the same independent association of
diastolic dysfunction with fat mass percentage, evaluated by bioim-
pedance analysis, which also strengthens the link between total adiposity
and worse diastolic function.nd several adiposity parameters according to age and sex.
≥65 years
Crude Adjusteda




0.02 (−0.06 to 0.09) 0.03 0.03 (−0.04 to 0.1) 0.45 0.27
−0.01 (−0.06 to 0.04) −0.01 −0.01 (−0.05 to 0.05) 0.94 0.24
−2.0 (−6.3 to 2.4) −0.06 0.4 (−4.0 to 4.9) 0.84 0.01
−0.11 (−0.22 to−0.01) −0.15 −0.13 (−0.24 to−0.03) 0.01 0.03
−0.06 (−0.13 to 0.01) −0.12 −0.07 (−0.13 to−0.01) 0.04 0.04
−7.9 (−14.5 to−1.2) −0.17 −8.6 (−14.9 to−2.3) 0.01 0.06
coefﬁcient.
Table 4
Path analysis with estimated total, direct and indirect effects of waist-to-height ratio on E′ velocity.
Women Men
b65 years ≥65 years b65 years ≥65 years
Total −4.985 (−8.377 to−1.592) −0.253 (−4.536 to 4.030) −15.698 (−22.051 to−9.346) −9.208 (−15.584 to−2.833)
Direct −1.703 (−5.818 to 2.412) 0.652 (−3.821 to 5.125) −12.762 (−19.520 to−6.005) −8.480 (−14.852 to−2.108)
Indirect — role of SBP −2.531 (−4.189 to−0.873) −0.998 (−2.157 to 0.162) −0.982 (−3.301 to 1.336) −0.521 (−1.522 to 0.481)
Indirect — role of hsCRP −0.751 (−2.723 to 1.221) 0.093 (−0.757 to 0.943) −1.954 (−3.902 to−0.005) −0.21 (−0.839 to 0.425)
CFI 0.990 1.000 0.946 1.000
Standardized regression coefﬁcients and 95% conﬁdence intervals (in parentheses) were calculated by bootstrapping using 1000 draws.
CFI, comparative ﬁt index; hsCRP, high sensitivity C reactive protein; SBP, systolic blood pressure.
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more closely relatedwith excess visceral fat, which is themostmetabol-
ically active fat [21]. Several studies have shown that compared to BMI,
abdominal obesity is a stronger determinant of myocardial infarction,
cardiovascular disease and death [32,33]. In our populationwe observed
that increased waist-to height ratio was a stronger determinant of dia-
stolic dysfunction, especially in men. The association between waist-to
height ratio and diastolic function was independent of BMI, which em-
phasizes a speciﬁc role for visceral fat. This observation is consistent
with recently published data, that have also shown that waist circum-
ference [34], and increased abdominal visceral fat mass assessed by CT
scan [35], are independent determinants of diastolic dysfunction, inde-
pendently of BMI and subcutaneous fat, respectively. The conﬁrmation
of abdominal obesity as a more important determinant of subclinical
left ventricle diastolic dysfunction might have important clinical impli-
cations, particularly by the increasing prevalence of obesity worldwide.
Interestingly, previous studies have observed an association between
waist circumference and incident heart failure [36], whichwas indepen-
dent of BMI [37]. Also, recent prospective studies have conﬁrmed that
subclinical diastolic dysfunction is associated with the development
of heart failure, especially with heart failure with preserved ejection
fraction (HFpEF) [27,38]. Therefore, the early identiﬁcation and cor-
rection of the main determinants of subclinical diastolic dys-
function, such as abdominal obesity, can be particularly important
in the prevention of HFpEF, a disease where no therapy has been
shown to change the prognosis. This will need to be conﬁrmed in fu-
ture longitudinal studies.
4.2. The role of sex in the association between adiposity and diastolic
dysfunction
The total amount of fat and its distribution is quite different in men
and women. It is known that younger women have a more peripheral
and subcutaneous distribution of fat but, later, menopause induces a
more abdominal distribution of fat with increasing age. Therefore, we
hypothesized that the effect on left ventricle diastolic function could
be sex- and age-speciﬁc. In this study we observed a stronger relation
between adiposity parameters and diastolic dysfunction in men than
inwomen, and this difference is especially apparent in the younger pop-
ulation. Most of the previous studies that have also evaluated the rela-
tion between obesity and diastolic function did not assess the sex
difference [29] or did not ﬁnd a signiﬁcant difference in effect [13].
However, Canepa et al., found that the association between waist cir-
cumference and diastolic function was more pronounced in women
than in men [34]. Nevertheless, these results could be partially ex-
plained by women being signiﬁcantly younger than men, bearing in
mind that in our study the association between adiposity and diastolic
function is also age dependent. Also, body composition differs signiﬁ-
cantly between racial and ethnical subgroups and our study was con-
ducted in a European population, while the study from Canepa et al.
included 29% of African origin participants.4.3. Direct and indirect mechanisms linking adiposity and diastolic
dysfunction
The pathophysiological pathways that link obesity with diastolic
dysfunction are not entirely understood. This association can bemediat-
ed by a combination of both direct and indirect effects that, according to
our results, seem to be sex speciﬁc. The effect can be indirect, through
established risk factors that can also induce diastolic dysfunction. Alter-
natively, this effect can be caused by the secretion of adipokines that
have been shown to modulate myocardial structure and function by
inducing a systemic pro-inﬂammatory effect and/or by causing direct
hemodynamic and mechanical changes in the heart and cardiovascular
system [28].
In our study, we have shown that the association between the sever-
al adiposity parameters and DD is partially attenuated when adjusting
for age andmainly for blood pressure, which is consistentwith previous
studies [13]. As shown in the path analysis, this indirect effect through
systolic blood pressure is especially important in younger women,
being responsible for about 50% of the effect. Interestingly, another
study including only patients with hypertension found that the adverse
effect of abdominal obesity on left ventricle diastolic function wasmore
pronounced among hypertensive females [39].
Adipose tissue is an important source of proinﬂammatory cytokines
[17]. Previous studies have linked inﬂammation with diastolic dysfunc-
tion in patients with hypertension [40] and coronary artery disease [41]
and, in experimental studies, the inhibition of inﬂammatory pathways
prevented diastolic dysfunction development [42]. Therefore, the role
of adiposity on diastolic dysfunction can be at least partially mediated
by inﬂammation. The path analysis that we have performed showed
that in individuals younger than 65 years, the effect of waist-to-height
ratio on diastolic dysfunction was mediated by hsCRP, which was
responsible for 12.4% and 15.1% of this indirect effect in men and
women, respectively. Interestingly, systemic inﬂammatory state has
been shown to be predictive of incident HF, especially of HFpEF [43]
and, more importantly, previous studies have proposed that the as-
sociation between obesity and HF may be related to pathophysio-
logic pathways associated with inﬂammation [44]. Combining all
these observations, Paulus and Tschope [45] have recently proposed
a novel paradigm for HFpEF development which identiﬁes a system-
ic proinﬂammatory state, induced by obesity and other comorbidi-
ties, as a cause of reduced nitric oxide availability and decreased
protein kinase G activity inducing stiffer cardiomyocytes and inter-
stitial ﬁbrosis deposition.
Finally, obesity can directly inﬂuence myocardial structure and func-
tion through othermechanisms, some not evaluated in this study. As ob-
served in the path analysis performed, inmen younger than 65 years, the
direct effect can be responsible for up to 80% of the association between
abdominal obesity and diastolic dysfunction. Several other pathophysio-
logical mechanisms can be involved. Adipose tissue is an endocrine
organ capable of secreting several adipokines (such as leptin,
adiponectin, resistin and others) that have been shown to induce left
69R. Fontes-Carvalho et al. / International Journal of Cardiology 191 (2015) 64–70ventricle remodeling and myocardial dysfunction [46]. Indeed, it has
been suggested that the association between obesity and HF may be
partially mediated by plasma leptin [28]. Also, obese patients have in-
creased myocardial fatty inﬁltration that can lead to the worse diastolic
dysfunction [47]. Furthermore, the excess in body fat determines an in-
crease in both preload and afterload, due to a hyperdynamic circulation,
chronic volume overload, and increase in peripheral resistance [48],
which have also been shown to inﬂuence diastolic function [49].
4.4. Strengths and limitations
To assess the pathophysiological mechanisms involved in the now
well-established association between increased adiposity and diastolic
dysfunctionwe used a path analysis, which is an extension of regression
analysis, being increasingly used to decompose and compare the mag-
nitudes of effects between variables with complex interrelations or to
test the plausibility of mediation effects. Other strengths of this study in-
clude the large sample of individuals free from other cardiac diseases, the
contemporaneous assessment of cardiac diastolic function using themost
recent consensus criteria for diastolic function evaluation and the use of
several adiposity parameters including anthropometry andbioimpedance
analysis to measure fat mass distribution.
Themain limitation of this study is the cross-sectional design, which
partially limits comments on causality, as thiswould bemore robust in a
prospective design. Although we have excluded patients with clinical
signs of coronary artery disease, we did not perform any stress test to
exclude myocardial ischemia, which is one determinant of diastolic
dysfunction. We did not evaluate the intraobserver and interobserver
variability in the evaluation of diastolic function. However, all the cardi-
ologists had extensive experience in echocardiography, worked in the
same institution and a detailed procedure protocol was discussed be-
tween the team, prior to study beginning in order to harmonize the
methodology and the measurements. Moreover, several previous stud-
ies have shown a good reproducibility and a low inter-observer mean
error for diastolic parameters [50].
5. Conclusion
Obesity, especially abdominal obesity, was associated with worse
diastolic function. This association was stronger in men than in women
and in the younger population. The causal mechanisms potentially in-
volved were sex-speciﬁc, being mainly mediated by blood pressure in
women, while in men there was mainly a direct effect.
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